Maria T Abreu

Title: Maria T Abreu: Innovator in Crohn's Disease Research

Introduction

Maria T Abreu is a prominent inventor based in New York, NY, who has made significant contributions to the field of medical research, particularly in understanding Crohn's disease. Her innovative work focuses on the genetic factors associated with this complex condition, providing valuable insights for diagnosis and treatment.

Latest Patents

Maria T Abreu holds a patent titled "Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease." This invention presents a method for diagnosing or predicting susceptibility to a specific clinical subtype of Crohn's disease characterized by fibrostenosing disease. The method involves determining the presence of a fibrostenosis-predisposing allele linked to the NOD2/CARD15 locus. The presence of this allele is diagnostic of susceptibility to the fibrostenosing subtype of Crohn's disease. Additionally, the invention outlines a method for optimizing therapy based on the diagnosis of individuals with this subtype.

Career Highlights

Maria T Abreu is affiliated with Cedars-Sinai Medical Center, where she continues her research and clinical work. Her dedication to advancing medical knowledge and improving patient outcomes is evident in her innovative approaches to understanding Crohn's disease.

Collaborations

Some of her notable coworkers include Kent D Taylor and Jerome I Rotter, who have collaborated with her on various research initiatives.

Conclusion

Maria T Abreu's contributions to the field of Crohn's disease research exemplify her commitment to innovation and patient care. Her work not only enhances our understanding of the disease but also paves the way for improved diagnostic and therapeutic strategies.